Citation Impact
Citing Papers
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
2015 StandoutNobel
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
2015 Standout
Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease
2008
The clinical symptoms of Parkinson's disease
2016 Standout
Glutamate receptor ion channels
2005 Standout
Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains
2003
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
2009 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Parkinson disease
2017 Standout
Olfaction in Parkinson's disease and related disorders
2011
Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms
2006
fMRIPrep: a robust preprocessing pipeline for functional MRI
2018 Standout
Parkinson's disease
2021 Standout
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
2009
The spectrum of neuromyelitis optica
2007 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis
2009
Malignant MCA Stroke: an Update on Surgical Decompression and Future Directions
2015
Biological and Clinical Implications of Comorbidities in Parkinson’s Disease
2017
Neuroimaging in Parkinson disease: from research setting to clinical practice
2014
Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease
2010
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Imaging in the era of molecular oncology
2008 StandoutNature
Neurochemistry and the non-motor aspects of PD
2011
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation
2012
Impulsivity, Compulsivity, and Top-Down Cognitive Control
2011 Standout
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system
2009
Overdependence on degraded gist memory in Alzheimer's disease.
2006 Standout
In vivo imaging of synaptic function in the central nervous system
2009
Application of Electrophysiologic Techniques in Poor Outcome Prediction Among Patients With Severe Focal and Diffuse Ischemic Brain Injury
2011
Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia
2006
Molecular Imaging Studies in Parkinson Disease
2009
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders
2016
Reflex control of immunity
2009 Standout
Aβ peptides can enter the brain through a defective blood–brain barrier and bind selectively to neurons
2007
Parkinson's disease
2015 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Regional homogeneity changes in patients with Parkinson's disease
2008
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
2010
REST: A Toolkit for Resting-State Functional Magnetic Resonance Imaging Data Processing
2011 Standout
Quantitative imaging biomarkers in neuro-oncology
2009
The ReSPonD trial - rivastigmine to stabilise gait in Parkinson’s disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson’s disease who have fallen
2013
Missing pieces in the Parkinson's disease puzzle
2010
New approaches for imaging tumour responses to treatment
2008
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Hypoglossal Neuropathology and Respiratory Activity in Pompe Mice
2011
Synthesis of Selective Agonists for the α7 Nicotinic Acetylcholine Receptor with In Situ Click-Chemistry on Acetylcholine-Binding Protein Templates
2012 StandoutNobel
N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
2010 Standout
Alzheimer's Disease
2010 Standout
Non-motor features of Parkinson disease
2017 Standout
Primary brain tumours in adults
2012 Standout
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
2007
Cholinergic modulation of microglial activation by α7 nicotinic receptors
2004
Neuronal nicotinic receptors: from structure to pathology
2004
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
2010 Standout
Imaging biomarkers in Parkinson's disease
2011
Intracellular accumulation of β-amyloid1–42 in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer’s disease
2002
Piezo2 senses airway stretch and mediates lung inflation-induced apnoea
2016 StandoutNatureNobel
Parkinson's disease‐cognitive rating scale: A new cognitive scale specific for Parkinson's disease
2008
Intracellular amyloid-β in Alzheimer's disease
2007 Standout
The cholinergic system in aging and neuronal degeneration
2010
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
2011
Pouring oil into the fire? On the conundrum of the beneficial effects of NMDA receptor antagonists in Alzheimer disease
2004
Triangulating a Cognitive Control Network Using Diffusion-Weighted Magnetic Resonance Imaging (MRI) and Functional MRI
2007
Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI
2012
From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease
2010
The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease
2011
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Ligand-Gated Ion Channels: New Insights into Neurological Disorders and Ligand Recognition
2012
The role of neurotransmitters in the development of Parkinson's disease‐related psychosis
2017
Nanoscale Metal–Organic Frameworks for Biomedical Imaging and Drug Delivery
2011 Standout
All three PACSIN isoforms bind to endocytic proteins and inhibit endocytosis
2000
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease
2005
The neurobiological basis of cognitive impairment in Parkinson's disease
2014
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
2009 Standout
Hidden fluid mechanics: Learning velocity and pressure fields from flow visualizations
2020 StandoutScience
Reversible Photocontrol of Biological Systems by the Incorporation of Molecular Photoswitches
2013 StandoutNobel
Recommendations for the Management of Cerebral and Cerebellar Infarction With Swelling
2014
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
Part 8: Post–Cardiac Arrest Care
2015 Standout
Activation of nicotinic acetylcholine receptor prevents the production of reactive oxygen species in fibrillar β amyloid peptide (1-42)-stimulated microglia
2008
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
2012 Standout
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
The MoCA
2010 Standout
Neurovascular Coupling in Parkinson's Disease Patients: Effects of Dementia and Acetylcholinesterase Inhibitor Treatment
2010
Family history of subarachnoid haemorrhage: supplemental value of scrutinizing all relatives.
1997 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
2019 Standout
Mechanisms of Endocytosis
2009 Standout
Physiology of Microglia
2011 Standout
Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings
2015
Works of Lothar Burghaus being referenced
Immunoadsorption in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy with Unsatisfactory Response to First-Line Treatment
2011
Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas
2006
Dementia in Parkinson disease
2005
Early electroencephalography in acute ischemic stroke: Prediction of a malignant course?
2006
Glykogenose Typ II (M. Pompe)
2005
Do negative CCT and CSF findings exclude a subarachnoid haemorrhage? A retrospective analysis of 220 patients with subarachnoid haemorrhage
2010
Loss of nicotinic acetylcholine receptor subunits α4 and α7 in the cerebral cortex of Parkinson patients
2003
Hallucinations in Neurodegenerative Diseases
2011
Evoked Potentials in Acute Ischemic Stroke within the First 24 h: Possible Predictor of a Malignant Course
2007
Prognostic value of electroencephalography and evoked potentials in the early course of malignant middle cerebral artery infarction
2012
Expression of nicotinic acetylcholine receptors in Alzheimer’s disease: postmortem investigations and experimental approaches
2000
Deep brain stimulation of the subthalamic nucleus reversibly deteriorates stuttering in advanced Parkinson’s disease
2005
Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients
2000
Subthalamic Nucleus Stimulation Restores Glucose Metabolism in Associative and Limbic Cortices and in Cerebellum: Evidence from a FDG-PET Study in Advanced Parkinson's Disease
2003
Recurrent longitudinal myelitis as primary manifestation of SLE
2004
Patient-Tailored, Imaging-Guided, Long-Term Temozolomide Chemotherapy in Patients with Glioblastoma
2010